Team:TMU-Tokyo

From 2013.igem.org

(Difference between revisions)
 
(9 intermediate revisions not shown)
Line 21: Line 21:
   <Hr>
   <Hr>
   <tr>
   <tr>
-
     <td><p>In the iGEM, most teams have inserted their Biobrick parts or devices into the plasmids and use them. It is true that there are many good points to use plasmids, for instance, it is easy to do transformation, and it is convenient to use high copy plasmid when you want to get high gene expression amount. However, there are some bad points to use plasmids too. For example, when the reproduction starting point of plural plasmids are covered, it can’t put in <i>E.coli</i> at the same time. Also it is difficult to control genetic expression closely.<br>
+
     <td><p>In the iGEM, most teams have inserted their Biobrick parts or devices into plasmids and have used them. It is true that there are many good points to use plasmids, for instance, it is easy to do transformation, and it is convenient to use high copy plasmid when you want to get high amount of gene expression. However, there are some bad points to use plasmids too. For example, when the reproduction starting point of plural plasmids are covered, they can’t be put in <i>E.coli</i> at the same time. Also it is difficult to control closely expression of the genes which are in .plasmids.</p>
-
<p>Therefore, in this year, our team tried to standardize a new method to inserted Biobrick parts or devices in a genome of E.coli and used them. Also we really inserted the device which we designed in a genome of <i>E.coli</i> according to our method and functionalized it.</p>
+
<p>Therefore, in this year, our team tried to establish and standardize a new method to insert Biobrick parts or devices in a genome of <i>E.coli</i> and use them. Also, according to this method, we really inserted the device which we designed in a genome of <i>E.coli</i> and functionalized it.</p>
 +
 
</td>
</td>
   </tr>
   </tr>
Line 37: Line 38:
       <td align="center">
       <td align="center">
         <table class="stand" rules="none" border="1" width="450" height="270">
         <table class="stand" rules="none" border="1" width="450" height="270">
-
           <tr  height="30"><td align="center"><b>Standardization</b></td></tr>
+
           <tr  height="30"><td align="center"><b>Standardization</b> -New method, “Breakthrough”-</td></tr>
-
           <tr height="200"><td style="padding:3px 7px;"><p><a href="https://2013.igem.org/Team:TMU-Tokyo/Project/NEWS" style="text-decoration:none; color:#000;">In order to insert Biobricks in to a genome of <i>E.coli</i> and functionalize them, we made a new and interesting method and standardize it. In this new method named “NEWS”, we constructed all of our parts by over rap extension PCR and inserted these PCR products in to a genome of <i>E.coli</i> by lambda bacteriophage recombination system, ”RED”. Also we designed a new parts which to improve the present designated vector. With this parts, it can be easily to do cloning the parts which made by PCR.<br>
+
           <tr height="200"><td style="padding:3px 7px;"><p><a href="https://2013.igem.org/Team:TMU-Tokyo/Project/NEWS" >In order to insert Biobricks in a genome of <i>E.coli</i> and functionalize them, we established a new and interesting method and standardize it. In this new method named “Breakthrough”, we constructed all of our parts by over rap extension PCR and inserted these PCR products into a genome of <i>E.coli</i> by lambda bacteriophage recombination system named ”RED”. Also we designed a new parts which to improve the present designated vector (pSB1C3). With this part, it can be easily to do cloning the parts which made by PCR.<br>
-
  <p>Additionally, we standardized this method so that other iGEMers could use it. So we’ll apply for New Standard prize.</p>
+
  Additionally, we standardized this method so that other iGEMers could use it. So<u> we’ll apply for New Standard prize.</u>
 +
</p>
</td></tr>
</td></tr>
         </table>
         </table>
Line 45: Line 47:
       <td align="center">
       <td align="center">
           <table class="imple" rules="none"  border="1" width="450" height="270" ">
           <table class="imple" rules="none"  border="1" width="450" height="270" ">
-
             <tr  height="30"><td align="center"><a href="www.google.co.jp"><b>Implementation</b> ―Genomic Pythagorean Device-</a></td></tr>
+
             <tr  height="30"><td align="center"><b>Implementation</b> ―Genomic Pythagorean Device-</a></td></tr>
            
            
           <tr height="200"><td style="padding:3px 7px;">
           <tr height="200"><td style="padding:3px 7px;">
-
           <p><a href="www.google.co.jp" style="text-decoration:none; color:#000;"> According to the system that we spoke in the right, we really inserted the device named “Genomic Pythagorean Device”, which we designed into a genome of <i>E.coli</i>. “Pythagorean Device” is very famous in Japan because Japanese famous educational TV program "Pythagorean Switch" introduces various Pythagorean Devices. They are known as "Rube Goldberg machines" in the US. Pythagorean Devices are deliberately over-engineered or overdone systems that perform very simple task in very complicated process, usually including some chain reactions. We constructed “Pythagorean Device” in <i>E.coli</i> genome with lambda phage recombination system "RED"</a></p></td></tr>
+
           <p><a href="https://2013.igem.org/Team:TMU-Tokyo/Project/Pythagorean_Device" > According to the method that we spoke in the right, we really inserted the device named “Genomic Pythagorean Device”, which we designed into a genome of <i>E.coli</i>. “Pythagorean Device” is very famous in Japan because Japanese famous educational TV program "Pythagorean Switch" introduces various Pythagorean Devices. They are known as "Rube Goldberg machines" in the US. Pythagorean Devices are deliberately over-engineered or overdone systems that perform very simple task in very complicated process, and they usually include some chain reactions. We constructed “Pythagorean Device” in a genome of <i>E.coli</i> and checked whether it functioned properly.</a></p></td></tr>
         </a></table>
         </a></table>
Line 125: Line 127:
         <table border="0" width="450" height="100" bgcolor="#fff">
         <table border="0" width="450" height="100" bgcolor="#fff">
       <tr>
       <tr>
-
         <td class="boximg" rowspan="2"><img src="https://static.igem.org/mediawiki/igem.org/1/11/TMUArrow.png"
+
         <td class="boximg" rowspan="2"><a href="https://2013.igem.org/Team:TMU-Tokyo/Project/Future_Plan">
 +
                                        <img src="https://static.igem.org/mediawiki/igem.org/1/11/TMUArrow.png"
                                         onmouseover="this.src='https://static.igem.org/mediawiki/igem.org/f/fe/TMUArrow_af.png';"
                                         onmouseover="this.src='https://static.igem.org/mediawiki/igem.org/f/fe/TMUArrow_af.png';"
-
                                         onmouseout="this.src='https://static.igem.org/mediawiki/igem.org/1/11/TMUArrow.png';"></td>
+
                                         onmouseout="this.src='https://static.igem.org/mediawiki/igem.org/1/11/TMUArrow.png';"></a></td>
         <td  colspan="2" rowspan="2">
         <td  colspan="2" rowspan="2">
           <li>What kind of application is imaginable ?</li>
           <li>What kind of application is imaginable ?</li>
Line 146: Line 149:
         <table border="0" width="450" height="100" bgcolor="#fff">
         <table border="0" width="450" height="100" bgcolor="#fff">
       <tr>
       <tr>
-
       <td class="boximg" rowspan="2"><img src="https://static.igem.org/mediawiki/igem.org/c/c8/TMUHeart.png"
+
       <td class="boximg" rowspan="2"><a href="https://2013.igem.org/Team:TMU-Tokyo/HumanPractice">
 +
                                      <img src="https://static.igem.org/mediawiki/igem.org/c/c8/TMUHeart.png"
                                         onmouseover="this.src='https://static.igem.org/mediawiki/igem.org/3/32/TMUHeart_af.png';"
                                         onmouseover="this.src='https://static.igem.org/mediawiki/igem.org/3/32/TMUHeart_af.png';"
-
                                         onmouseout="this.src='https://static.igem.org/mediawiki/igem.org/c/c8/TMUHeart.png';"></td>
+
                                         onmouseout="this.src='https://static.igem.org/mediawiki/igem.org/c/c8/TMUHeart.png';"></a></td>
         <td  colspan="2" rowspan="2">
         <td  colspan="2" rowspan="2">
-
           <li>Are there any relation with our project ?</li>
+
           <li>What did we do to promote Synthetic Biology?</li>
           </td>
           </td>
         </tr>
         </tr>
Line 177: Line 181:
         <table border="0" width="450" height="100" bgcolor="#fff">
         <table border="0" width="450" height="100" bgcolor="#fff">
       <tr>
       <tr>
-
         <td class="boximg" rowspan="2"><img src="https://static.igem.org/mediawiki/igem.org/2/23/TMUSafety.png"
+
         <td class="boximg" rowspan="2"><a href="https://2013.igem.org/Team:TMU-Tokyo/Safety">
 +
                                      <img src="https://static.igem.org/mediawiki/igem.org/2/23/TMUSafety.png"
                                         onmouseover="this.src='https://static.igem.org/mediawiki/igem.org/5/5a/TMUSafety_af.png';"
                                         onmouseover="this.src='https://static.igem.org/mediawiki/igem.org/5/5a/TMUSafety_af.png';"
-
                                         onmouseout="this.src='https://static.igem.org/mediawiki/igem.org/2/23/TMUSafety.png';"></td>
+
                                         onmouseout="this.src='https://static.igem.org/mediawiki/igem.org/2/23/TMUSafety.png';"></a></td>
         <td  colspan="2" rowspan="2">
         <td  colspan="2" rowspan="2">
           <li>What did we do for securing of safety ?</li>
           <li>What did we do for securing of safety ?</li>
Line 197: Line 202:
         <table border="0" width="450" height="100" bgcolor="#fff">
         <table border="0" width="450" height="100" bgcolor="#fff">
       <tr>
       <tr>
-
         <td class="boximg" rowspan="2"><img src="https://static.igem.org/mediawiki/igem.org/5/52/TMUTrophy.png"
+
         <td class="boximg" rowspan="2"><a href="https://2013.igem.org/Team:TMU-Tokyo/Achievement">
 +
                                      <img src="https://static.igem.org/mediawiki/igem.org/5/52/TMUTrophy.png"
                                         onmouseover="this.src='https://static.igem.org/mediawiki/igem.org/a/a2/TMUTrophy_af.png';"
                                         onmouseover="this.src='https://static.igem.org/mediawiki/igem.org/a/a2/TMUTrophy_af.png';"
-
                                         onmouseout="this.src='https://static.igem.org/mediawiki/igem.org/5/52/TMUTrophy.png';"></td>
+
                                         onmouseout="this.src='https://static.igem.org/mediawiki/igem.org/5/52/TMUTrophy.png';"></a></td>
         <td  colspan="2" rowspan="2">
         <td  colspan="2" rowspan="2">
           <li>What did we achieve in our project ?</li>
           <li>What did we achieve in our project ?</li>
Line 247: Line 253:
</A>
</A>
<A href="http://www.comp.tmu.ac.jp/dousoukai/"><IMG Src="https://static.igem.org/mediawiki/2012/e/e1/Dousoukai.sp.jpg" border="0">
<A href="http://www.comp.tmu.ac.jp/dousoukai/"><IMG Src="https://static.igem.org/mediawiki/2012/e/e1/Dousoukai.sp.jpg" border="0">
 +
<a href="http://www.ikedarika.co.jp/"><img src="https://static.igem.org/mediawiki/igem.org/c/c2/Ikeda_logo.gif" >
<Br>
<Br>
<Br>
<Br>

Latest revision as of 02:49, 28 September 2013



Project description


In the iGEM, most teams have inserted their Biobrick parts or devices into plasmids and have used them. It is true that there are many good points to use plasmids, for instance, it is easy to do transformation, and it is convenient to use high copy plasmid when you want to get high amount of gene expression. However, there are some bad points to use plasmids too. For example, when the reproduction starting point of plural plasmids are covered, they can’t be put in E.coli at the same time. Also it is difficult to control closely expression of the genes which are in .plasmids.

Therefore, in this year, our team tried to establish and standardize a new method to insert Biobrick parts or devices in a genome of E.coli and use them. Also, according to this method, we really inserted the device which we designed in a genome of E.coli and functionalized it.



Standardization -New method, “Breakthrough”-

In order to insert Biobricks in a genome of E.coli and functionalize them, we established a new and interesting method and standardize it. In this new method named “Breakthrough”, we constructed all of our parts by over rap extension PCR and inserted these PCR products into a genome of E.coli by lambda bacteriophage recombination system named ”RED”. Also we designed a new parts which to improve the present designated vector (pSB1C3). With this part, it can be easily to do cloning the parts which made by PCR.
Additionally, we standardized this method so that other iGEMers could use it. So we’ll apply for New Standard prize.

Implementation ―Genomic Pythagorean Device-

According to the method that we spoke in the right, we really inserted the device named “Genomic Pythagorean Device”, which we designed into a genome of E.coli. “Pythagorean Device” is very famous in Japan because Japanese famous educational TV program "Pythagorean Switch" introduces various Pythagorean Devices. They are known as "Rube Goldberg machines" in the US. Pythagorean Devices are deliberately over-engineered or overdone systems that perform very simple task in very complicated process, and they usually include some chain reactions. We constructed “Pythagorean Device” in a genome of E.coli and checked whether it functioned properly.


 
  • What is our goal?
  • Why is there a need for our project?
  • Why do we insert parts in a genome?
  • What Biobrick parts did we design ?
  • Which parts did we submit ?
  • Did our parts work ?
  • What kind of application is imaginable ?
  • What is necessary to improve our project ?
  • What did we do to promote Synthetic Biology?
  • What did we do for securing of safety ?
  • What did we achieve in our project ?


  • contact us!!




    tmutokyo.igem@gmail.com